|
Match
|
Document |
Document Title |
|
|
7605183 |
Inhibitory or blocking agents of molecular generating and/or inducing functions
A method for inhibiting or blocking molecular generating and/or inducing functions of molecules using an inhibitory or blocking agent of the formula:
wherein R1-6 are as defined herein.
|
|
|
7589123 |
Chemical compounds
Compounds of general formula I:
wherein:
R 1 and R 2 are, independently of each other, selected from hydrogen, optionally substituted C 1-10 alkyl, optionally substituted —CO—(C 1-10...
|
|
|
7586008 |
Propofol analogs, process for their preparation, and methods of use
The invention provides para substituted dialkylphenol derivatives of propofol. The invention further provides pharmaceutical compositions comprising such analogs, methods for preparing such...
|
|
|
7579016 |
Methods for repelling arthropods using isolongifolenone analogs
A method for for repelling arthropods involving treating an object or area with an arthropod repelling effective amount of at least one isolongifolenone analog (and optionally a carrier or carrier...
|
|
|
7566737 |
Combinations of substituted 1,3-diphenylprop-2-en-1-one derivatives with other therapeutically active ingredients
The invention concerns novel substituted 1,3-diphenylprop-2-en-1-one derivatives and combinations of said derivatives with other therapeutically active ingredients. The invention also concerns...
|
|
|
7537774 |
Therapeutic formulation
A pharmaceutical composition including a salt of rhodizonic acid, an OH anion-generating base, a non-toxic acid, a quinone, a salt-containing sulfite, catechol and, optionally, an acetogenin. The...
|
|
|
7531695 |
Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
The present invention is directed to compounds having the structure (I) wherein R 1 , R 2 , R 3 , R 4 , R 5 and m are as defined herein. The compounds of this invention are novel therapeutic...
|
|
|
7501454 |
Cyclohexenone compounds from Antrodia camphorata to treat autoimmune diseases
The present invention relates to a compound of Antrodia camphorata used to treat autoimmune diseases, in particular to an extract,...
|
|
|
7497901 |
Tungstate and molybate wood preservatives
Complexes of copper and/or zinc with molybdate and/or tungstate were solubilized in ammonia or ammoniacal solution providing preservative solutions that fully penetrate wood. With loss of the...
|
|
|
7468392 |
Anti-fatigue cyclohexenone compounds from antrodia camphorata
The present invention relates to a compound of Antrodia camphorata used to delay physiological fatigue, in particular to a extract isolated from Antrodia camphorata,...
|
|
|
7456225 |
Liver protection compounds of the cyclohexenone type from Antrodia camphorata
The present invention relates to a compound of Antrodia camphorata used for liver protection, in particular to an extract,...
|
|
|
7431940 |
Methods for treatment of human skin damaged by laser treatment or chemical peelings and compositions useful in such methods
Methods for treatment of human skin damaged by laser treatment or chemical peelings comprise the topical application of an effective amount of a lamellar oil-in-water system. In accordance with the...
|
|
|
7427316 |
Tropolone complexes as wood preservatives
Complexes of tropolone and copper and/or zinc were solubilized in ammoniacal solution providing preservative solutions that fully penetrate wood. With loss of the ammonia from the wood, the...
|
|
|
7417072 |
Blockade of Pin1 prevents cytokine production by activated immune cells
The invention provides pharmaceutical compositions and methods of treating immunological disorders. The invention also provides pharmaceutical compositions and methods of inducing eosinophil...
|
|
|
7411003 |
Inhibition of Hepatitis B virus by cyclohexenone compounds from Antrodia camphorata
The present invention relates to a compound of Antrodia camphorata used to inhibit HBV, in particular to an extract,...
|
|
|
7399888 |
Anticonvulsant compounds
The invention relates to novel isoxylitones and their use as anticonvulsant and in the treatment of a variety of disorders.
|
|
|
7374901 |
Method of analyzing coenzyme Q-10 and two-electron reduction product thereof and analysis system
The present invention relates to an analysis method and analysis system that can accurately analyze the contents of coenzyme Q-10 and a 2-electron reduced form thereof in a specimen, in which human...
|
|
|
7365096 |
Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)
Methods are disclosed for inhibiting or disrupting Janus tyrosine kinase 3 (Jak3) dependent function in cells of lymphoid or myeloid origin, especially for blocking proliferation and function of...
|
|
|
7335688 |
Bicyclic cannabinoid agonists for the cannabinoid receptor
Novel polycyclic cannabinoid analogs are presented which have preferentially high affinities for the cannabinoid CB2 receptor sites. The improved receptor affinity makes these analogs...
|
|
|
7311923 |
Harmful-insect-eliminating formed resin article and animal collar using the same
Disclosed is a harmful-insect-eliminating formed resin article, wherein the article contains a 1,2-polybutadiene resin and a volatile harmful-insect-eliminating component, e.g. eucalyptol and...
|
|
|
7211604 |
Compounds for blocking androgen receptors
Compounds used to block non-essential androgen receptors are described. In particular, cyclohexenone compounds containing an alkyl group may be used in the treatment of conditions mediated by the...
|
|
|
7202279 |
Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
The present invention provides 4-substituted-2-azetidinone compounds, bicyclic 2-5-diketopiperazine compounds, and pharmaceutical compositions thereof that are potent, safe and effective...
|
|
|
7199161 |
Substituted bicylo[3.3.1]nonan-2,4,9-triones as pharmaceutical active ingredients
The invention relates to the use of substituted bicyclo[3.3.1]nonan-2,4,9-triones, especially clusianon and clusianon derivatives, as pharmaceutical active ingredients or medicamentous active...
|
|
|
7166642 |
Use of cyclohexenone long-chain alcohol for treating neurodegenerative diseases
A preventive and therapeutic drug for a neurodegenerative disease containing, as an active ingredient, a cyclohexenone long-chain alcohol compound represented by formula (1) wherein each of R 1 , R...
|
|
|
7135501 |
Clusianon isomers and use thereof
The invention relates to a clusianon isomer and to the use thereof, in particular as a pharmaceutical or medical active ingredient, in particular for producing medicaments for the prophylactic...
|
|
|
7132458 |
Oxidized carotenoid fractions and ketoaldehyde useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents
This invention features fractionated oxidized carotenoid or retinoid mixtures, and individual components thereof, which are useful as cell-differentiation-inducing, anti-proliferative,...
|
|
|
7094804 |
Water free ubiquinone concentrate
A water soluble, essentially water-free ubichinon concentrate is described, which contains an emulsifier with an HLB value between 9 and 16, ubichinon Q 10 , as well as a light oil containing...
|
|
|
RE39150 |
Composition for creating vascular occlusions
A composition including 2-hexyl cyanoacrylate and goal is useful in treating arteriovenous malformations (AVMs) and other body lumens to be blocked.
|
|
|
7015252 |
Compositions for lessening oxidative stress
The present invention provides an antioxidative composition with high safety, which is capable of lessening oxidative stress due to active oxygen species, free radicals, or the like in vivo,...
|
|
|
7005453 |
Use of hop acids to inhibit growth of Staphylococcus aureus and prevent toxic shock syndrome
The present invention provides methods, products, and compositions for selectively inhibiting the growth of Staphylococcus aureus without preventing the growth of Lactobacillus species....
|
|
|
6979688 |
Treatment method against side-effects of chemotherapy
A method and composition is provided for organ rescue wherein a specific counter-measure is applied locally to a tissue at risk for or exhibiting an adverse side effect of a cancer treatment. More...
|
|
|
6964969 |
Composition and method for treating impaired or deteriorating neurological function
A nutritional supplement composition for normalizing impaired or deteriorating neurological function in humans is composed of: at least one agent which promotes synthesis of ATP and/or creatine...
|
|
|
6939897 |
Method and composition for inhibiting arteriosclerosis
The present invention has for its object to provide a method and a composition for achieving a more efficient recovery of the antioxidant activity of plasma LDL, or even augmentation thereof, which...
|
|
|
6927211 |
Method for reducing toxicity of combined chemotherapies
Compositions and methods are provided for use in the treatment of cancer.
|
|
|
6906107 |
Use of cyclohexenone derivatives for the manufacture of a medicament in the treatment of dysuria
A preventive and/or therapeutic agent for dysuria, which comprises as an effective ingredient a cyclohexenone long-chain alcoholic derivative represented by the following formula (1): [wherein, R 1...
|
|
|
6906106 |
Compositions for the skin comprising fibers and ubiquinones and methods of using the same
The present invention relates to a composition for topical application on the skin, comprising fibers and at least one or two or more compounds selected from the group of the ubiquinones and...
|
|
|
6890525 |
Semiochemical
cis-Jasmone has been discovered to be useful as a semiochemical that changes the behaviour of insects and/or the physiology of plants. It has direct signalling roles with plant-feeding aphids, in...
|
|
|
6890524 |
Hydrolyzable delivery system using cross-linked polymeric resins as vehicles
This invention provides a method of preparing a polymeric delivery system for active ingredients. The delivery system is formed either by attaching the active ingredient to a linker through a...
|
|
|
6849276 |
Liquid composition with fungicide, bactericidal and bacteriostatic activity
The invention concerns a phytosanitary fungicide, bactericidal or bacteriostatic composition comprising at least a mineral salt, a copper oxide or hydroxide suspended in an aqueous emulsion of at...
|
|
|
6803367 |
Substance for inducing apoptosis
A substance for inducing apoptosis represented by specific formulae. A pharmaceutical composition which can be used for an anticancer agent containing said substance.
|
|
|
6790463 |
Uses of targeted oxidative therapeutic formulation in arteriosclerosis
The use of a pharmaceutical formulation in treating coronary arteriosclerosis and a two-component pharmaceutical formulation. The pharmaceutical formulation contains peroxidic species or reaction...
|
|
|
6787572 |
Use of ubiquinone Q10 for the local treatment and prevention of post-surgical ophthalmologic pathologies
In the treatment of ophthalmologic pathologies in general and in particular in the treatment and prevention of side-effects on eye following photorefractive therapy (PRK), laser-assisted in situ...
|
|
|
6710090 |
Inhibitory or blocking agents of molecular generating and/or inducing functions
A method for inhibiting or blocking molecular generating and/or inducing functions of molecules using an inhibitory or blocking agent of the formula: wherein R1-6 and A are as defined herein.
|
|
|
6696498 |
2-cyclopenten-1-one and its derivatives as inhibitors of the NF-kB factor
2-Cyclopenten-1-one and its derivatives comprising the cyclopentenone nucleus as inhibitors of the NF-kB factor, with anti-inflammatory, anti-proliferative-immuno-suppressive, cytoprotective and...
|
|
|
6696483 |
Inhibitors of angiogenesis and tumor growth for local and systemic administration
The invention provides pharmaceutical formulations and methods for the treatment of individuals suffering from a condition, disease, or disorder that is treatable by the inhibition of angiogenesis....
|
|
|
6686396 |
Noxious-insect repellent
Disclosed is a method of repelling noxious insects comprising the step of exposing said noxious insects to a composition containing from 0.1 to 90 wt. %, based on the total weight of the...
|
|
|
6660288 |
Insect repellents
The use of specific perfume ingredients, e.g. tricyclodecenyl allyl ether, to repel insects. The perfume ingredients may be used in a composition comprising from 0.1 to 40 percent by weight of one...
|
|
|
6646008 |
Treatment of disease states which result from neoplastic cell proliferation using PPAR-&ggr activators and compositions useful therefor
In accordance with the present invention, it has been discovered that PPARγ is expressed consistently in tissues associated with each of a variety of disease states which result from neoplastic...
|
|
|
6576673 |
Method of deterring woodpeckers
A method of making a coating for deterring woodpeckers from damaging wood using Isophorone and the composition made therefrom. The Isophorone is combined with heated wax and combined with a...
|
|
|
6576660 |
Methods and compositions for regulation of 5-α-reductase activity
Compounds that inhibit 5-alpha-reductase are provided. The compounds are used to treat prostate cancer, breast cancer, obesity, skin disorders and baldness.
|